European Archives - Page 726 of 1331 - European Medical Journal

EMJ Hematology 10 [Supplement 1] 2022

Multiple myeloma (MM) is an incurable disease and is the second most common haematologic malignancy in the world. Over the past decade…

Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…

A Case Report on a Novel PINK1 Gene Mutation in a Female with a Neurodegenerative Disorder

Parkinson’s disease (PD) is a progressive neurodegenerative disorder attributed to the loss of dopaminergic neurons in the substantia nigra.

Microbiol-Infect-Dis-CP-940x572

Trends in Infectious Diseases: A Retrospective 5-Year Study

A wide variety of infections contribute to acute care admissions to general internal medical units.

Are AI systems Ready to be Introduced into Prostate Cancer Care?

AI systems can identify and grade prostate cancer tissue samples as accurately as pathologists, which could lead to their use as a complementary tool…

Experts Concerned by the Rise in Young-Onset Cancers

Evidence revealed by researchers at Flinders University and UCLA has demonstrated a rise in gastrointestinal cancers in those under 50…

Medicine’s Past, Present, and Future

Jonathan and Jeffrey Ponsky discuss innovative approaches to surgery, and the evolution of medical training.

Cancer treatment collaboration announced

Queen’s University Belfast has entered into a collaboration and licensing agreement with Ipsen to research, develop, manufacture and commercialise FLIP inhibitors.

EMJ Neurology 10 [Supplement 1] 2022

This symposium review of presentations made at the World Muscle Society (WMS) 2021 Virtual Congress draws a spotlight upon two monogenic neuromuscular diseases: spinal muscular atrophy (SMA) and Duchenne muscular dystrophy.

New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy

Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.